Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU advocate general condemns financial incentives for prescribers

This article was originally published in SRA

Executive Summary

European Court of Justice Advocate General Niilo Jääskinen has issued an opinion that puts the brakes on a UK health service scheme to control healthcare expenditure through a specific form of drug substitution1. In Association of the British Pharmaceutical Industry v Medicines and Healthcare products Regulatory Agency, the advocate general also makes it clear that providing financial incentives to influence prescribing practices is unlawful not only for commercial concerns, but also for state authorities.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS115052

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel